Introduction: Despite the large number of caregivers suffering from various psychiatric disorders, research on psychological symptoms among caregivers of hospitalized patients is lacking in Saudi populations. Objectives: The objective of this study is to determine the prevalence of depression, anxiety and stress among caregivers of hospitalized Saudi patients. Methods: A cross-sectional study of depression, anxiety and stress among caregivers of hospitalized patients was conducted. Arabic speaking caregivers (n = 353) between the ages of 14 and 80 years were included in the study. The Depression Anxiety Stress Scales (DASS-21) test (Arabic version) was used to measure the three psychological symptoms. Results: The study has shown high rates of depression, anxiety and stress among caregivers (72.8%, 76.5%, and 61.5%, respectively). Depression was found to be associated with long-term hospital stay (81.4% vs. 69.3%; p-value = 0.021) and family caregivers (75.4% vs. 46.9%, p-value = 0.001). Anxiety was found to be associated with family caregivers (78.8% vs. 53.1%; p-value = 0.001). The three psychological symptoms were higher among those with an age above 20 years old (p-value < 0.05). Multivariate logistic models show the risk of the psychological symptoms increased with low-income, higher education, immediate relation to the patient, and older caregivers. Conclusions: The findings suggest that the prevalence of depression, anxiety and stress symptoms were very common among caregivers. The results showed that approximately 8 out of 10 caregivers suffer from at least one psychiatric disorder. Older, low socioeconomic status, and well-educated caregivers were identified as being at higher risk of developing psychiatric symptoms.

Cancer is a genome disease, initiated by mutations in genes that usually control cell growth and division. Matrix metalloproteinases (MMPs) have important roles in both of tumor invasion and spread.The

Respiratory viral infections (RVIs) commonly cause morbidity and mortality in hematopoietic stem cell transplant (HSCT) recipients. This study aimed at the prevalence of RVIs in adult HSCT recipients and their outcomes. A retrospective observational cohort study was conducted on all adult patients who underwent HSCT in the period between January 2016 and December 2020. Data were retrospectively abstracted from electronic medical records from a total of 400 patients. All cases with polymerase chain reaction-confirmed RVIs based on real-time reverse transcription polymerase chain reaction were included in the data analysis. A total of 79 patients had positive results. Sixty-three patients had allogeneic stem cell transplants. Women were 53% of the patients, and the mean age was 32 years (±13.5). The prevalence of documented respiratory virus infections was around 20% during the 4 years of the study. The most common virus was rhinovirus (60.76%), followed by respiratory syncytial virus (15.19%), then parainfluenza (11.39%). Among the 9 patients (11%) who required intensive care unit admission, 67% had lymphopenia (P = .03), 71% had abnormal chest computed tomography scan with pleural effusion (P = .03), 22% required renal support (P = .057), and 2 patients (22%) died (P = .057). The study highlights the associated morbidity and mortality with RVIs among HSCT recipients and the need for more preventive measures and treatment studies.

Background: Magnusiomyces clavatus (formerly Geotrichum clavatum/Saprochaete clavata ) is a yeast with a filamentous form, as well as an uncommon, yet emerging opportunistic pathogen. It occurs primarily in patients experiencing prolonged neutropenia, and there is limited evidence available to guide antifungal agent selection and treatment decisions. Case Summary: We present a case of disseminated infection caused by M. clavatus in a patient with myelofibrosis following allogeneic hematopoietic stem cell transplantation. The patient was treated with voriconazole, as well as liposomal amphotericin B, along with granulocyte transfusion. The patient died from persistent fungemia, refractory septic shock, and multiorgan failure 20 days after the infection was first diagnosed. Conclusion: We subsequently discuss the epidemiological, clinical, and therapeutic features of this severe fungal infection and present a review of currently available literature.

Mycobacterium riyadhense ( M. riyadhense ) is a slow‐growing nontuberculous mycobacterium that is increasingly being recognized as a cause of pulmonary and extrapulmonary disease, primarily in Saudi Arabia. Here, we report a case of M. riyadhense with an unusual presentation as a central nervous system mass, with an initial diagnosis of neurosarcoidosis and notable improvement with the use of steroids and rituximab prior to establishing the final diagnosis.